Barclays PLC Arrowhead Pharmaceuticals, Inc. Call Options Transaction History

Barclays PLC

  • $377 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 15, 2024
BUY
$19.36 - $29.54 $484,000 - $738,500
25,000 New
25,000 $484,000
Q1 2024

May 15, 2024
BUY
$27.21 - $39.48 $625,830 - $908,039
23,000 Added 76.67%
53,000 $1.52 Million
Q4 2023

Feb 15, 2024
BUY
$21.2 - $31.03 $636,000 - $930,900
30,000 New
30,000 $918,000
Q2 2022

Aug 12, 2022
BUY
$27.79 - $50.61 $1.28 Million - $2.33 Million
46,000 New
46,000 $1.62 Million

Others Institutions Holding ARWR

# of Institutions
294
Shares Held
90.8M
Call Options Held
155K
Put Options Held
426K
View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

ARWR Quotes by TradingView
  • Ticker ARWR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,849,000
  • Market Cap $2.07B
  • Description
  • Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...
More about ARWR
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email